Cannabis

The Cannabis market in APAC is forecasted to reach US$4.57bn in 2024.
It is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 2.45%, leading to a market volume of US$5.16bn by 2029.
When compared globally, the United States will generate the highest revenue (US$42.98bn in 2024).
In terms of per capita figures, each individual generates revenues of US$86.92 in 2024.
Australia's growing acceptance of cannabis for medical and recreational use is fueling a surge in investment opportunities in the APAC cannabis market.

Definition:
The Cannabis market covers products derived from the cannabis plant used for medical or recreational purposes. These products may include dried flowers, oils, edibles, tinctures, and topicals. Depending on the regulations in each country or state, these products are provided by dispensaries, pharmacies, and/or online platforms. They may be consumed in the form of smoking, vaporizing, eating, or applying topically.

Structure:
The market includes Medical, Pharmaceutical, and Recreational Cannabis as well as CBD Products. The Medical and Pharmaceutical Cannabis markets include products used to treat conditions such as chronic pain, mental disorders, and other medical conditions. The Recreational Cannabis and the the CBD Products markets include products used for personal enjoyment or leisure purposes. All cannabis markets include various forms of cannabis such as flowers, concentrates, edibles, and topicals.

Additional information:
Market values represent the revenues generated by retail prices paid to vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Canopy Growth Corporation, Aurora Cannabis, Curaleaf Holdings, Tilray, Green Thumb Industries, Trulieve Cannabis, Verano Holdings.

Recreational Cannabis
Medical Cannabis
Pharmaceutical Cannabis
CBD Products

Illegal cannabis
Cannabis cultivated for private use

The Cannabis market in APAC is experiencing significant growth and development, driven by shifting customer preferences, evolving trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the APAC region are increasingly seeking out cannabis products for medicinal and recreational purposes. There is a growing acceptance of the potential health benefits of cannabis, leading to a rise in demand for CBD-infused products. Additionally, there is a trend towards more sophisticated consumption methods, such as vaporizers and edibles, reflecting a desire for convenience and discretion.

Trends in the market: In countries like Japan, South Korea, and Thailand, where cannabis regulations have historically been strict, there is a gradual shift towards legalization for medical use. This trend is driven by changing societal attitudes, as well as a recognition of the economic potential of the cannabis industry. As a result, there is a growing number of companies entering the market and developing innovative cannabis-based products to meet the evolving needs of consumers.

Local special circumstances: In countries like India and Malaysia, where cannabis has a long history of traditional and cultural use, there is a unique opportunity to leverage local knowledge and practices in the development of cannabis products. This presents a competitive advantage for companies looking to cater to the preferences of these markets and differentiate themselves from international competitors. Additionally, the diverse regulatory landscape across the APAC region means that companies must navigate varying legal frameworks and cultural norms to successfully operate in different countries.

Underlying macroeconomic factors: The rapid urbanization and increasing disposable income levels in many APAC countries are contributing to the growth of the cannabis market. As more people move to cities and experience lifestyle changes, there is a greater demand for alternative healthcare and wellness products, including cannabis. Furthermore, the COVID-19 pandemic has accelerated the acceptance of e-commerce and digital platforms for purchasing cannabis products, providing new opportunities for market expansion and reaching a wider customer base.

Data coverage:

Data encompasses B2B and B2C enterprises. Figures are based on companies' revenues, funding values and global consumer survey data. Revenues include retail, sales and taxes.

Modeling approach / Market size:

Market sizes are determined by a Top-Down approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports, third-party data. Next, we use relevant key market indicators and data from country-specific associations such as tobacco spending per capita, medical product spending per capita, consumer spending and consumer spending for recreation purposes, population. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Cannabis or marijuana, the psychoactive drug from the cannabis plant is growing in popularity around the globe, both for recreational and medicinal uses. While there are many countries that have legalized cannabis in some capacity for medical purposes, only a handful have done so for recreational use. Even though cannabis is not federally legal in the United States, the combined legal states represent the largest market in the world. After the U.S., Canada, which legalized cannabis nation-wide in 2018 represents the next largest market. In 2021, a new coalition government was formed in Germany that indicated that the legalization of cannabis was on their agenda. Germany would be the largest legal adult-use market in Europe and would act as a test case for other countries on the continent considering the merits of legalization.